The impact of changed treatment patterns in multiple myeloma on health-care utilisation and costs, myeloma complications, and survival: A population-based comparison between two time periods in Denmark.
Louise Hur HannigLene Kongsgaard NielsenRikke IbsenLisen Arnheim-DahlströmJakob KjellbergNiels AbildgaardPublished in: European journal of haematology (2021)
Despite the introduction of new expensive early-line MM treatments in 2009, health-care costs remained stable due to a shift in health-care utilisation towards outpatient clinic care and fewer complications.